|
|
| | ZFZDDBJAFMOQSH-UHFFFAOYSA-N Basic information |
| Product Name: | ZFZDDBJAFMOQSH-UHFFFAOYSA-N | | Synonyms: | ZFZDDBJAFMOQSH-UHFFFAOYSA-N;PG 106;L-Lysinamide, N-acetyl-L-norleucyl-L-α-aspartyl-β-alanyl-3-(2-naphthalenyl)-D-alanyl-L-arginyl-L-tryptophyl-, (2→7)-lactam;(3S,6S,9R,16S,24S)-3-((1H-Indol-3-yl)methyl)-16-((S)-2-acetamidohexanamido)-6-(3-guanidinopropyl)-9-(naphthalen-2-ylmethyl)-2,5,8,11,15,18-hexaoxo-1,4,7,10,14,19-hexaazacyclotetracosane-24-carboxamide | | CAS: | 944111-22-2 | | MF: | C51H69N13O9 | | MW: | 1008.2 | | EINECS: | | | Product Categories: | | | Mol File: | 944111-22-2.mol |  |
| | ZFZDDBJAFMOQSH-UHFFFAOYSA-N Chemical Properties |
| density | 1.40±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble to 1 mg/ml in 25% ethanol / water | | form | Powder | | pka | 13.09±0.70(Predicted) |
| | ZFZDDBJAFMOQSH-UHFFFAOYSA-N Usage And Synthesis |
| Uses | PG 106 Hexafluorophosphate TFA Salt is a selective human melanocortin receptor 3 (hMC3R) antagonist which may be used to differentiate the substructural features responsible for selectivity at the hMC3R, hMC4R, and hMC5R. |
| | ZFZDDBJAFMOQSH-UHFFFAOYSA-N Preparation Products And Raw materials |
|